Anonymous19 days ago
The American College of Cardiology and American Heart Association released sweeping new cholesterol management guidelines on March 13, 2026, recommending lower LDL targets, statin treatment starting as young as age 30, and universal screening for lipoprotein(a) — a genetically determined cholesterol marker affecting an estimated 64 million Americans. The guidelines, which replace the 2018 framework, represent a fundamental shift toward lifetime cardiovascular risk prevention and incorporate five new FDA-approved therapies, but have also reignited debate over the expanding scope of statin prescriptions.